Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Hepatology. 2022 Nov 3;77(2):530–545. doi: 10.1002/hep.32777

Table 2.

Biomarker Comparisons* between disease groups and controls

Control BA A1AT ALGS

LOX
(ng/mL)
Mean 5.0 3.9 3.8 3.1
p-value Ref. 0.045 0.22 0.004

MMP-3
(ng/mL)
Mean 12.1 9.9 7.2 9.3
p-value Ref. 0.003 <0.001 0.4

Endoglin
(pg/mL)
Mean 7,958 11,117 9,295 10,118
p-value Ref. <0.001 0.2 0.23

TIMP-1
(ng/mL)
Mean 171 134 135 176
p-value Ref. <0.001 <0.001 0.29

Mac-2BPGi
(ng/mL)
Mean 5.5 3.9 4.0 3.5
p-value Ref. 0.002 0.003 <0.001

Periostin
(pg/mL)
Mean 6,968 3,002 2,785 3,895
p-value Ref. <0.001 <0.001 <0.001

IL-8
(pg/ML)
Mean 99 44 39 45
p-value Ref. <0.001 <0.001 0.006

CTGF
(Pg/mL)
Mean 695 518 601 434
p-value Ref. 0.01 0.6 0.001

MMP-7
(ng/mL)
Mean 3.4 6.8 3.5 3.4
p-value Ref. <0.001 0.26 0.41
*

p-values based on Kruskal-Wallis tests